Cited by 734Telomeres, Telomerase, and SenescenceImmunotherapy and Immune ResponsesVirus-based gene therapy research

The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.

Telomerase and cancer therapeutics

Harley, Calvin B.·2008·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Telomerase is an attractive cancer target as it appears to be required in essentially all tumours for immortalization of a subset of cells, including cancer stem cells. Moreover, differences in telomerase expression, telomere length and cell kinetics between normal and tumour tissues suggest that targeting telomerase would be relatively safe. Clinical trials are ongoing with a potent and specific telomerase inhibitor, GRN163L, and with several versions of telomerase therapeutic vaccines. The prospect of adding telomerase-based therapies to the growing list of new anticancer products is promising, but what are the advantages and limitations of different approaches, and which patients are the most likely to respond?

Integrity signals

Registry

Crossref · 10.1038/nrc2275

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Akiyama, M., Hideshima, T., Shammas, M. A., Hayashi, T., Hamasaki, M., Tai, Y., Richardson, P. G. G., Gryaznov, S. M., Munshi, N. C., & Anderson, K. C. (2003) · PubMed · Cited by 84
Retracted
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citation
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citation
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280

Show all 147 references

Research works printed but not linked: 1

Dikmen, Z. et al. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res. 7866–7873 (2005). · DOI · Paper page

Sorted by citations

Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Nanomedicine Applications of Hybrid Nanomaterials Built from Metal–Ligand Coordination Bonds: Nanoscale Metal–Organic Frameworks and Nanoscale Coordination Polymers
He, C., Liu, D., & Lin, W. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00125 · Cited by 1,011
Untitled work
Wang (2012) · doi:10.1161/circresaha.111.261388 · Cited by 957
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Totoki, Y., Tatsuno, K., Covington, K. R., Ueda, H., Creighton, C. J., Kato, M., Tsuji, S., Donehower, L. A., Slagle, B. L., Nakamura, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3126 · Cited by 781
Role of Telomeres and Telomerase in Aging and Cancer
Shay, J. W. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0062 · Cited by 668
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
Silencing disease genes in the laboratory and the clinic
Watts, J. K., & Corey, D. R. (2011) · The Journal of Pathology · doi:10.1002/path.2993 · Cited by 493
Pro-senescence therapy for cancer treatment
Nardella, C., Clohessy, J. G., Alimonti, A., & Pandolfi, P. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3057 · Cited by 437
A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
Sun, Y., Xun, K., Wang, Y., & Chen, X. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330d95b · Cited by 418
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
Telomerase directly regulates NF-κB-dependent transcription
Ghosh, A., Saginc, G., Leow, S. C., Khattar, E., Shin, E. M., Yan, T. D., Wong, M., Zhang, Z., Li, G., Sung, W.-K., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2621 · Cited by 378
The roles of senescence and telomere shortening in cardiovascular disease
Fyhrquist, F., Saijonmaa, O. J., & Strandberg, T. E. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.30 · Cited by 373
A mechanistic classification of clinical phenotypes in neuroblastoma
Ackermann, S., Cartolano, M., Hero, B., Welte, A., Kahlert, Y., Roderwieser, A., Bartenhagen, C., Walter, E., Gecht, J., Kerschke, L., et al. (2018) · Science · doi:10.1126/science.aat6768 · Cited by 348
Telomerase: An RNP Enzyme Synthesizes DNAPreprint
Blackburn, E. H., & Collins, K. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003558 · Cited by 333
Deubiquitinases in cancer
Dewson, G., Eichhorn, P. J. A., & Komander, D. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00633-y · Cited by 353
DNAzyme-Based Biosensors: Immobilization Strategies, Applications, and Future Prospective
Khan, S. A., Burciu, B., Filipe, C. D. M., Li, Y., Dellinger, K., & Didar, T. F. (2021) · ACS Nano · doi:10.1021/acsnano.1c04327 · Cited by 329
Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA
Xu, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00134a · Cited by 326
Novel anticancer therapeutics targeting telomerase
Ruden, M., & Puri, N. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.007 · Cited by 324
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Block, K. I., Gyllenhaal, C., Lowe, L. J., Amedei, A., Amin, A. R. M. R., Amin, A., Aquilano, K., Arbiser, J. L., Arreola, A., Arzumanyan, A. L., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.007 · Cited by 308
Rationally Engineered Nucleic Acid Architectures for Biosensing Applications
Xiao, M., Lai, W., Man, T., Chang, B., Li, L., Chandrasekaran, A. R., & Pei, H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00121 · Cited by 291
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells
Liu, Z., Li, Q., Li, K., Chen, L., Li, W., Hou, M., Liu, T., Yang, J., Lindvall, C., Björkholm, M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.441 · Cited by 276
Telomere-driven diseases and telomere-targeting therapies
Martínez, P., & Blasco, M. A. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610111 · Cited by 257
“Telomeres as therapeutic targets • martínez and Blasco 883 notherapy, gene therapy using telomerase promoter-driven expression of a suicide gene, and chemicals that block telomerase biogenesis (Harley, 2008; Agrawal et al., 2012; Buseman et al., 2012; Jafri et al., 2016).”
Background
ALTernative Telomere Maintenance and Cancer
Dilley, R. L., & Greenberg, R. A. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.07.007 · Cited by 251
The role of telomeres and telomerase in cirrhosis and liver cancer
Nault, J., Ningarhari, M., Rebouissou, S., & Zucman‐Rossi, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0165-3 · Cited by 255
Senescence: a new weapon for cancer therapy
Acosta, J. C., & Gil, J. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.006 · Cited by 235
The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
Marian, C. O., Cho, S. K., Mcellin, B. M., Maher, E. A., Hatanpaa, K. J., Madden, C. J., Mickey, B., Wright, W. E., Shay, J. W., & Bachoo, R. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2850 · Cited by 224
New viruses for cancer therapy: meeting clinical needs
Miest, T. S., & Cattaneo, R. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3140 · Cited by 222
A ‘higher order’ of telomere regulation: telomere heterochromatin and telomeric RNAs
Schoeftner, S., & Blasco, M. A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.197 · Cited by 232
Telomeric repeat-containing RNA TERRA: a noncoding RNA connecting telomere biology to genome integrity
Cusanelli, E., & Chartrand, P. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00143 · Cited by 219
Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA
Mitchell, M. T., Gillis, A., Futahashi, M., Fujiwara, H., & Skordalakes, E. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1777 · Cited by 205
Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis
Singhapol, C., Pal, D., Czapiewski, R., Porika, M., Nelson, G., & Saretzki, G. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052989 · Cited by 198
A Robust Probe for Lighting Up Intracellular Telomerase via Primer Extension To Open a Nicked Molecular Beacon
Qian, R., Ding, L., Yan, L., Lin, M., & Ju, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5042995 · Cited by 195
Sensitive Electrochemical Detection of Telomerase Activity Using Spherical Nucleic Acids Gold Nanoparticles Triggered Mimic-Hybridization Chain Reaction Enzyme-Free Dual Signal Amplification
Wang, W., Li, J., Rui, K., Gai, P., Zhang, J., & Zhu, J. (2015) · Analytical Chemistry · doi:10.1021/ac504652e · Cited by 164
The Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
Brunsvig, P. F., Kyte, J. A., Kersten, C., Sundstrøm, S. H., Møller, M., Nyakas, M., Hansen, G. L., Gaudernack, G., & Aamdal, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1385 · Cited by 159
Architecture of human telomerase RNA
Zhang, Q., Kim, N.-K., & Feigon, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100279108 · Cited by 162
HPV E6 protein interacts physically and functionally with the cellular telomerase complex
Liu, X., Dakic, A., Zhang, Y., Dai, Y., Chen, R., & Schlegel, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906357106 · Cited by 156
The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
Joseph, I., Tressler, R., Bassett, E., Harley, C. B., Buseman, C. M., Pattamatta, P., Wright, W. E., Shay, J. W., & Go, N. F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0233 · Cited by 147
Self-citation
Therapeutic Targeting of Telomerase
Jäger, K., & Walter, M. (2016) · Genes · doi:10.3390/genes7070039 · Cited by 144
Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?
Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G. T., & Kassem, M. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.07.004 · Cited by 141
The diagnosis and treatment of dyskeratosis congenita: a review
Feldstein, J. T., & Garcia, S. F. (2014) · Journal of Blood Medicine · doi:10.2147/jbm.s47437 · Cited by 140
WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells
Zhang, K., Guo, Y., Wang, X., Zhao, H., Ji, Z., Cheng, C., Li, L., Fang, Y., Xu, D., Zhu, H. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1887 · Cited by 134
Oncological role of HMGA2 (Review)
Zhang, S., Mo, Q., & Wang, X. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4856 · Cited by 137
Telomere Length and Oxidative Stress and Its Relation with Metabolic Syndrome Components in the Aging
Gavia-García, G., Rosado-Pérez, J., Arista-Ugalde, T. L., Aguíñiga-Sánchez, I., Santiago‐Osorio, E., & Mendoza-Núñez, V. M. (2021) · Biology · doi:10.3390/biology10040253 · Cited by 148
Properties of Protein Drug Target Classes
Bull, S. C., & Doig, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117955 · Cited by 146
The mutational landscape of hepatocellular carcinoma
Lee, J. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.3.220 · Cited by 134
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma
Gandolfi, G., Ragazzi, M., Frasoldati, A., Piana, S., Ciarrocchi, A., & Sancisi, V. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0837 · Cited by 130
Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532
Bryan, C., Rice, C., Hoffman, H., Harkisheimer, M. J., Sweeney, M. A., & Skordalakes, E. (2015) · Structure · doi:10.1016/j.str.2015.08.006 · Cited by 131
Game changers in science and technology - now and beyond
Betz, U. A. K., Arora, L., Assal, R. A., de Azevedo, H. F. Z., Baldwin, J., Becker, M. S., Bostock, S., Cheng, V. W. T., Egle, T., Ferrari, N., et al. (2023) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2023.122588 · Cited by 153
Structure of active dimeric human telomerase
Sauerwald, A., Sandin, S., Cristofari, G., Scheres, S. H. W., Lingner, J., & Rhodes, D. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2530 · Cited by 133
Telomerase Reverse Transcriptase Locus Polymorphisms and Cancer Risk: A Field Synopsis and Meta-Analysis
D, S. M. M., Verdi, D., Pooley, K. A., Landi, M. T., Egan, K. M., Baird, D. M., Prescott, J., Vivo, I. D., & Nitti, D. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs222 · Cited by 135
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
Steensma, D. P., Fenaux, P., Eygen, K. V., Raza, A., Santini, V., Germing, U., Font, P., Díez‐Campelo, M., Thépot, S., Vellenga, E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01895 · Cited by 125
Theileria-transformed bovine leukocytes have cancer hallmarks
Tretina, K., Gotia, H. T., Mann, D. J., & da Silva, J. C. F. (2015) · Trends in Parasitology · doi:10.1016/j.pt.2015.04.001 · Cited by 128
Inhibiting cancer cell hallmark features through nuclear export inhibition
Sun, Q., Chen, X., Zhou, Q., Burstein, E., Yang, S., & Jia, D. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.10 · Cited by 128
Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis
Hannen, R., & Bartsch, J. W. (2018) · FEBS Letters · doi:10.1002/1873-3468.13084 · Cited by 127
Targeting apoptosis pathways in cancer stem cells
Signore, M., Ricci‐Vitiani, L., & Maria, R. D. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.013 · Cited by 126
Telomerase and the search for the end of cancer
D, S. M. M., Pooley, K. A., & Nitti, D. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.006 · Cited by 121
Long telomeres and cancer risk among 95 568 individuals from the general population
Rode, L., Nordestgaard, B. G., & Bojesen, S. E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw179 · Cited by 120
New prospects for targeting telomerase beyond the telomere
Arndt, G. M., & MacKenzie, K. L. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.55 · Cited by 120
Telomere Dynamics in Human Cells Reprogrammed to Pluripotency
Suhr, S. T., Chang, E. A., Rodriguez, R. M., Wang, K., Ross, P. J., Beyhan, Z., Murthy, S., & Cibelli, J. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008124 · Cited by 107
Assays for human telomerase activity: progress and prospects
Zhou, X., & Xing, D. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35045a · Cited by 118
Novel functions for small RNA molecules.
Zhang, C. (2009) · PubMed · Cited by 119
Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA
Maji, B., & Bhattacharya, S. (2014) · Chemical Communications · doi:10.1039/c4cc00611a · Cited by 118
Telomeric transcripts stimulate telomere recombination to suppress senescence in cells lacking telomerase
Yu, T.-Y., Kao, Y.-W., & Lin, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307415111 · Cited by 117
A Cooperatively Activatable, DNA‐based Fluorescent Reporter for Imaging of Correlated Enzymatic Activities
Fan, Z., Zhao, J., Chai, X., & Li, L. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202104408 · Cited by 116
Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
Kyte, J. A., Gaudernack, G., Dueland, S., Trachsel, S., Julsrud, L., & Aamdal, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0184 · Cited by 111
Causes and consequences of nuclear envelope alterations in tumour progression
Bell, E. S., & Lammerding, J. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.06.007 · Cited by 115
Enzyme Inhibitors and Activators
Şentürk, M. (2017) · InTech eBooks · doi:10.5772/63325 · Cited by 113
Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
Godet, Y., Fabre, E., Dosset, M., Lamuraglia, M., Levionnois, É., Ravel, P., Benhamouda, N., Cazes, A., Pimpec‐Barthes, F. L., Gaugler, B., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3185 · Cited by 131
Nanogap‐Rich Au Nanowire SERS Sensor for Ultrasensitive Telomerase Activity Detection: Application to Gastric and Breast Cancer Tissues Diagnosis
Eom, G., Kim, H., Hwang, A., Son, H. Y., Choi, Y., Moon, J., Kim, D., Lee, M., Lim, E., Jeong, J., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201701832 · Cited by 108
Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy
Röth, A., Harley, C. B., & Baerlocher, G. M. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_16 · Cited by 113
Self-citation
Neural Stem Cells of the Subventricular Zone as the Origin of Human Glioblastoma Stem Cells. Therapeutic Implications
Matarredona, E. R., & Pastor, Á. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00779 · Cited by 110
RNA helicases in infection and disease
Steimer, L., & Klostermeier, D. (2012) · RNA Biology · doi:10.4161/rna.20090 · Cited by 108
The 5′ Guanosine Tracts of Human Telomerase RNA Are Recognized by the G-Quadruplex Binding Domain of the RNA Helicase DHX36 and Function To Increase RNA Accumulation
Sexton, A. N., & Collins, K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01033-10 · Cited by 107
From bench to bedside: the growing use of translational research in cancer medicine.
Goldblatt, E. M., & Lee, W. (2010) · PubMed Central · Cited by 106
Deregulated GSK3 Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase
Mai, W., Kawakami, K., Shakoori, A., Kyo, S., Miyashita, K., Yokoi, K., Jin, M., Shimasaki, T., Motoo, Y., & Minamoto, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0973 · Cited by 104
Efforts to make and apply humanized yeast
Laurent, J. M., Young, J. H., Kachroo, A. H., & Marcotte, E. M. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv041 · Cited by 108
PML body meets telomere
Chung, I., Osterwald, S., Deeg, K. I., & Rippe, K. (2012) · Nucleus · doi:10.4161/nucl.20326 · Cited by 114
Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels
Kretzner, L., Scuto, A., Dino, P. M., Kowolik, C. M., Wu, J., Ventura, P. B., Jove, R., Forman, S. J., Yen, Y., & Kirschbaum, M. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2259 · Cited by 103
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 101
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
Wu, R., Ayhan, A., Maeda, D., Kim, K.-R., Clarke, B. A., Shaw, P. H., Chui, M. H., Rosen, B. P., Shih, I., & Wang, T. (2013) · The Journal of Pathology · doi:10.1002/path.4315 · Cited by 103
Separation of telomerase functions by reverse genetics
Mukherjee, S., Firpo, E. J., Wang, Y., & Roberts, J. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112414108 · Cited by 104
TERT promoter mutations in primary liver tumors
Nault, J., & Zucman‐Rossi, J. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.07.006 · Cited by 104
Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria
Chiodi, I., & Mondello, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00133 · Cited by 98
Cancer vaccination with telomerase peptide GV1001
Kyte, J. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902897631 · Cited by 95
An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer
Qin, Y., Tang, B., Hu, C.-J., Xiao, Y., Xie, R., Yong, X., Wu, Y.-Y., Dong, H. F., & Yang, S. (2015) · Oncotarget · doi:10.18632/oncotarget.5968 · Cited by 93
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
Zgajnar, N. R., Leo, S. A. D., Lotufo, C. M., Erlejman, A. G., Piwien‐Pilipuk, G., & Galigniana, M. D. (2019) · Biomolecules · doi:10.3390/biom9020052 · Cited by 95
Telomerase Triggered DNA Walker with a Superhairpin Structure for Human Telomerase Activity Sensing
Huang, J., Zhu, L., Ju, H., & Lei, J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01603 · Cited by 93
Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity
D’Ambrosio, K., Fiore, A. D., Alterio, V., Langella, E., Monti, S. M., Supuran, C. T., & Simone, G. D. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00278 · Cited by 98
Tumor suppressive functions of ceramide: evidence and mechanisms
Galadari, S., Rahman, A. U., Pallichankandy, S., & Thayyullathil, F. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1109-1 · Cited by 97
New Insights in Amyloid Beta Interactions with Human Telomerase
Wang, J., Zhao, C., Zhao, A., Li, M., Ren, J., & Qu, X. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511030s · Cited by 90
Reliable Förster Resonance Energy Transfer Probe Based on Structure-Switching DNA for Ratiometric Sensing of Telomerase in Living Cells
Yang, X., Zhang, K., Zhang, T., Xu, J., & Chen, H. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00267 · Cited by 90
Novel coumarin-dihydropyrazole thio-ethanone derivatives: Design, synthesis and anticancer activity
Wu, X., Huang, C. Z., Jia, Y., Song, B.-A., Li, J., & Liu, X. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.014 · Cited by 90
Chromatin regulation and non-coding RNAs at mammalian telomeres
Schoeftner, S., & Blasco, M. A. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.09.015 · Cited by 96
DNA Logic Circuits for Cancer Theranostics
Chen, J., Fu, S., Zhang, C., Liu, H., & Su, X. (2022) · Small · doi:10.1002/smll.202108008 · Cited by 90
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) induces cancer cell senescence by interacting with telomerase RNA component
Nicholls, C., Pinto, A. R., Li, H., Li, L., Wang, L., Simpson, R. J., & Liu, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206672109 · Cited by 86
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 92
A Smart DNA Tweezer for Detection of Human Telomerase Activity
Xu, X., Wang, L., Li, K., Huang, Q., & Jiang, W. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05373 · Cited by 85
New trends in molecular and cellular biomarker discovery for colorectal cancer
Aghagolzadeh, P., & Radpour, R. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5678 · Cited by 87
Regulation of DNA Double-Strand Break Repair by Non-Coding RNAs
Thapar, R. (2018) · Molecules · doi:10.3390/molecules23112789 · Cited by 86

Authors: Harley, C. B.
Affiliations: Geron (United States) (US)
Corresponding author: Harley, Calvin B.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2008-03
Volume: 8
Issue: 3
Pages: 167-179
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2275
OpenAlex: W2078805336
Cited by: 728
References: 147
Citations by year: 2026: 11 · 2025: 22 · 2024: 26 · 2023: 39 · 2022: 20 · 2021: 29 · 2020: 38 · 2019: 39 · 2018: 27 · 2017: 38 · 2016: 48 · 2015: 58 · 2014: 48 · 2013: 51 · 2012: 53
FWCI: 6.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords: telomerase, telomerase inhibitors, GRN163L, cancer therapeutics, cancer stem cells, telomere length, cell kinetics, anticancer drug development
MeSH terms: Antineoplastic Agents, Clinical Trials as Topic, Enzyme Inhibitors, Humans, Immunotherapy, Kinetics, Medical Oncology, Models, Biological, Neoplasms, Oligonucleotides, Oligopeptides, Gene Expression Regulation, Neoplastic, Telomerase, Cancer Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Telomerase and cancer therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks